Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis
Key facts
- Who runs it
- Universitas Padjadjaran
- Where
- Indonesia2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 78 people enrolled
- Started
- 2 Aug 2025
- Ended
- 8 Dec 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Vitamin D
- Record updated
- 5 February 2026
Who can take part
- Age
- 0 days to 84 days
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients diagnosed with neonatal sepsis based on positive blood or cerebrospinal fluid cultures, or who meet the criteria for suspected sepsis with a Rodwell hematologic scoring system result of ≥3
- Parents or legal guardians are willing to participate in the study and sign the informed consent form
Who cannot take part
- Patients with major congenital malformations such as anencephaly, encephalocele, holoprosencephaly, hydrocephalus, meningomyelocele, spina bifida, omphalocele, gastroschisis, or congenital heart disease
- If during the 7-day monitoring period, a patient who was initially able to feed develops a medical condition requiring fasting (NPO)
- If during the 7-day monitoring period, a patient who initially had a medical condition requiring fasting is later able to feed again
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn the effect of vitamin D as an adjunctive therapy for preterm neonates with sepsis measured by the outcomes, which are sepsis score and C-reactive protein after 7 days. The main questions it aims to answer are:
Read full original descriptionShow less
Is there a difference in the results of the sepsis score (Modified Tollner Score and Sepsis Prediction Score) between groups of preterm neonates with sepsis who were given vitamin D as adjuvant therapy at doses of 400 IU/day, 800 IU/day, and those who were only given antibiotics?
Is there a difference in CRP levels between groups of preterm neonates with sepsis who were given vitamin D as adjuvant therapy at doses of 400 IU/day, 800 IU/day, and those who were only given antibiotics?
Participants will be divided into 3 groups:
Group 1 consisted of subjects who were given only antibiotics due to medical conditions requiring fasting.
Group 2 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 400 IU once daily for 7 days.
Group 3 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 800 IU once daily for 7 days.
The 3 groups in the trial
- Antibiotics onlyNo study treatment, for comparison
Group 1 consisted of subjects who were given only antibiotics due to medical conditions requiring fasting.
- Vitamin D 400 IUExisting treatment, for comparison
Group 2 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 400 IU once daily for 7 days.
Treatment: Vitamin D
- Vitamin D 800 IUExisting treatment, for comparison
Group 3 consisted of subjects who were able to receive enteral nutrition, were given antibiotics, and were supplemented with vitamin D3 at a dose of 800 IU once daily for 7 days.
Treatment: Vitamin D
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Vitamin D Administration on Sepsis Score and C-Reactive Protein Levels in Preterm Infants With Neonatal Sepsis
- Publications
- Record updated
- 5 February 2026